Extensive safety tests must be conducted before marketing food, drugs, and chemicals. Unfortunately, these tests often involve animal testing. Luckily, The TIM Company, a member of the First Dutch family of companies, offers an alternative with its artificial gastrointestinal model. This unique technology has the capability of replacing animal testing in such studies. By simulating dynamic conditions in the stomach and intestines, TIM allows safety studies to be conducted with great accuracy. TIM’s effectiveness has already been proven in over 250 scientific publications.
The TIM Company is more than just an ordinary technology; it is a revolutionary system that has been in development for over 30 years. In 2016, First Dutch acquired the innovative TIM system from TNO companies. Although TNO had invested heavily in the technology, it still needed to be brought to market when First Dutch took over. Fortunately, First Dutch recognised TIM’s potential and invested heavily to continue its development, despite the high costs and uncertainties.
Thanks to these investments, TIM has avoided over 5000 animal tests today and has grown into a thriving company with around 40 employees. As a result, TIM is paving the way for a future of innovation in which sustainability and ethics are at the forefront.